Table 1 Characteristics of the primary studies included in the meta-analysis.

From: The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis

Id	Author	Year	Countries	Prevalence	Sample size	Mean age	Disease duration	Risk score	References
1	Venter G	2021	Australia	14.7	109	59.5	204	Moderate	⁶⁹
2	Tavassoli S	2021	Iran	8.5	129	56.33	83	Low	⁷
3	Pierini F. S	2021	Argentina	36.5	74	62.1	114	Low	¹³
4	Hu Z	2021	China	54.7	340	59.4	66	Low	⁴
5	Tong J	2019	China	33.6	865	55.6	113	Low	⁶⁸
6	Lindner L	2020	Germany	6	5423	63	168	Low	⁵¹
7	Hu Z	2020	China	62.1	452	58	67	Low	⁴³
8	Yan S	2019	China	4.19	788	56	48	Low	⁷²
9	Wafa H	2018	Tunisia	48	173	54.1	98	Low	⁷¹
10	Tong H	2018	China	35	320	54.1	72	Low	⁶⁷
11	Luque Ramos A	2019	Germany	25.9	2535	62.5		Moderate	⁵²
12	Fauny M	2019	France	26.7	105	61.1	144	Low	³⁰
13	Phuan-udom R	2018	Thailand	5	232	61.1	155	Moderate	¹¹
14	Panopoulos S	2018	Greece	21.4	182	61.6	108	Low	⁶²
15	Mohd-Tahir N. A	2017	Malaysia	29	93	61.7	66	Moderate	⁵⁹
16	Kweon S. M	2018	South Korea	19.7	76	64.5	37.5	Low	⁴⁷
17	Kim D	2018	South Korea	33.8	142,955	54.2	24.5	High	⁴⁵
18	Heidari B	2018	Iran	30.8	39	50.6	108	Low	⁴¹
19	Gabdulina G	2018	Kazakhstan	45.1	406	50.6	61.6	Low	³¹
20	Ene C. G	2018	Romania	32.2	62	49.43		Low	²⁹
21	Choi S. T	2018	South Korea	33.4	479	61.5	53	Low	²⁷
22	Rossini M	2017	Italian	35	183	64	108	Moderate	⁶⁵
23	Meng J	2017	China	41.07	168	54.3	146.5	Low	²⁰
24	Makhdoom A	2017	Pakistan	40.6	229	46.4		Low	⁵³
25	Galarza-Delgado D. A	2017	Mexico	19.1	225	55.7	114	Moderate	³²
26	Singh S	2016	India	5.9	51	45		Low	¹
27	Lee J. H	2016	South Korea	46.8	1322	63.7	145	Low	⁵⁰
28	Kim D	2016	South Korea	5.5	5376	58.8	117.5	Low	⁴⁴
29	Innala L	2016	Sweden	3.7	726	55.6	80.5	Moderate	³
30	Garip Y	2016	Turkey	21.2	160	53.6	145	Low	³³
31	Bautista-Molano W	2016	Colombia	17.3	1652	58	110.5	Low	²⁶
32	Piao H. H	2015	China	21.6	37	64.4		Moderate	⁶³
33	Mohammad A	2013	Ireland	59	603	57	180	Low	⁵⁸
34	Lee J. H	2014	South Korea	59.1	545	57	135	Low	⁴⁹
35	Lee J. H	2014	South Korea	51	100	61.2	78	Low	⁴⁸
36	Hauser B	2014	UK	29.9	304	63.5	115	Low	⁴⁰
37	Gron K. L	2014	34 countries	17.6	9874	54.9	97	Moderate	³⁷
38	Mobini m	2012	Iran	32.3	121	55.7	121	Low	⁵⁷
39	Lee S. G	2012	South Korea	22.1	299	52.4	32	Low	¹⁶
40	Gonzalez-Lopez L	2012	Mexico	24.1	191	52	132	Low	³⁶
41	Ghazi M	2012	France	55.4	101	56.1	179.5	Low	³⁴
42	Vis M	2011	(Norway, UK, Netherlands)	35	102	61	204	Moderate	⁷⁰
43	Dao H. H	2011	Vietnam	27.6	105	56.3	21	Low	²⁸
44	Kim S. Y	2010	USA	18	47,034	55		Low	⁴⁶
45	El Maghraoui A	2010	Morocco	44.2	172	49.4	101	Low	¹⁸
46	Shankar S	2008	India	22	84	33.9	60	Low	⁶⁶
47	Sarkis K. S	2009	Brazil	25.3	83	55	92.5	Low	⁸
48	Richards J. S	2009	USA	18	282	65.4	156	Moderate	⁶⁴
49	Oelzner P	2008	Germany	47.8	551	58.4	144	Low	⁶¹
50	Haugen I. K	2007	Norway	19.4	194	60.9		Low	³⁹
51	Nolla J. M	2006	Spain	13	187	60.34	109	Low	⁶⁰
52	Mikuls T. R	2005	USA	4.7	175	60	109	Low	⁵⁶
53	Heidari B	2004	Iran	25	88	52.6	84	Low	⁴²
54	Manrique F	2003	Venezuela	29.4	85	45.3	113	Low	⁵⁴
55	Haugeberg G	2000	Norway	4.2	394	54.8	156	Moderate	³⁸
56	Gilboe I. M	2000	Norway	5	75	45	95	Low	³⁵
57	Moconkey B	1962		30.3	97	63.1	14.7	Moderate	⁵⁵

Back to article page

Table 1 Characteristics of the primary studies included in the meta-analysis.

Search

Quick links